Cancer Pharm Flashcards
What is the MOA of alkylating agents?
They form covalent linkages with DNA to prevent them from unwinding and replicating
non cycle specific
What is the acute toxicity associated with alkylating agents
nausea and vomiting within 30-60 mins
Pretreat with a serotonin antagonist
What are the delayed toxicities assoc with alkylating agents
bone marrow depression with leukopenia, thrombocytopenia, nephrotoxicity, alopecia, mycosal ulceration, intestinal denudation
What specific toxicity is associated with cyclophosphamide
hemorrhagic cystitis
What specific toxicity is associated with cisplatin
renal tubular damage, ototoxicity
What specific toxicity is associated with busulfan
pulmonary fibrosis
What are the main categories of antimetabolites
folic acid analogs (methotrexate) pyrimidine analogs (5FU) Purine analogs (6-MP)
MOA of methotrexate
Methotrexate inhibits dihydrofolate reductase
What drug is used in conjunction with high-dose methotrexate therapy to rescue normal cells
leucovorin
MOA of 5-FU
pro-drug
FdUMP blocks synthesis of thymidylate
FdUTP gets incorporated into DNA and interferes with DNA synthesis and function
FUTP gets incorporated into RNA and interferes with RNA processing and mRNA translation
MOA of 6-MP
metabobolized by HGPRT to form monophosphate nucleotide 6-thioinosinic acid
Simultaneous administration of _____ and PO 6-MP results in increased levels of 6-MP and increased toxicity
allopurinol
Pharm effects of antimetabolites
S phase specific
relatively little acute toxicity after initial dose
Common toxicities include diarrhea, myelosuppression, nausea, vom, immunosuppression, thromobocytopenia, leukopenia, hepatotoxicity
MOA of vinca alkaloids (vinblastine and vincristine
bind to B-tubulin and inhibit microtubule assembly (depolarization)
M phase specific
common adverse effects include alopecia and bone marrow suppression
Vinblastine adverse effect
causes myelosuppression to a greater extent than vincristine